NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma
- 13 February 2020
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 476, 48-56
- https://doi.org/10.1016/j.canlet.2020.02.008
Abstract
No abstract availableKeywords
Funding Information
- RGC General Research Fund (13120892)
This publication has 37 references indexed in Scilit:
- Nrf2 is required to maintain the self-renewal of glioma stem cellsBMC Cancer, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- NRF2 and cancer: the good, the bad and the importance of contextNature Reviews Cancer, 2012
- Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinomaNature Genetics, 2012
- Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 PathwayAntioxidants and Redox Signaling, 2010
- Sorafenib in Advanced Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- Activation of Hepatic Stem Cell Marker EpCAM by Wnt–β-Catenin Signaling in Hepatocellular CarcinomaCancer Research, 2007
- Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor CellsGastroenterology, 2007
- Increased susceptibility to hepatocarcinogenicity of Nrf2‐deficient mice exposed to 2‐amino‐3‐methylimidazo[4,5‐f]quinolineCancer Science, 2006
- Activation of the hedgehog pathway in human hepatocellular carcinomasCarcinogenesis: Integrative Cancer Research, 2006